Group 1: Fund Market Overview - The equity market experienced fluctuations, with the ChiNext Index rising by 2.35% while the Sci-Tech 50 Index fell by over 5% [2] - Among the 31 Shenwan first-level industries, 9 industries saw an increase, with the top five being electrical equipment, comprehensive, non-ferrous metals, pharmaceutical biology, and textile clothing [2] - The average decline for quantitative funds was 0.98%, while equity funds fell by an average of 0.61%, with a positive return ratio of 37.08% [2] Group 2: ETF Market Overview - The ETF market saw a net inflow of 477.03 billion yuan, with cross-border ETFs attracting a significant inflow of 134.17 billion yuan [3] - The average daily trading volume in the ETF market reached 4,781.81 billion yuan, with a turnover rate of 11.33% [3] - Major inflow products included broker, chemical, and Hang Seng technology-themed ETFs, while broad-based ETFs experienced outflows [3] Group 3: Industry Insights - The sports industry is projected to exceed 7 trillion yuan by 2030, with new policies aimed at enhancing sports consumption and high-quality development [5][7] - The recent policy changes in Shenzhen's real estate market led to a 40% increase in new home subscriptions, indicating a recovery in the real estate sector [6][7] - The light industry and textile sectors outperformed the CSI 300 Index, with the light industry gaining 1.13 percentage points and the textile sector gaining 2.18 percentage points [6] Group 4: Company Announcements - Wanlima won a procurement project from Southern Power Grid, indicating growth opportunities [6] - Zhiou Technology plans to transfer up to 122.85 million shares to no more than 46 employees, reflecting internal growth strategies [6] Group 5: Market Strategy - The report maintains a "neutral" rating for the light industry and textile sectors, with a positive outlook on companies like Oppein Home, Sophia, and Semir Clothing [7] - The increase in packaging paper prices is expected to improve profitability for major paper manufacturers in the short term [6][7]

Macro and Strategy Research - The U.S. economy is experiencing a shift in the balance of risks between inflation and employment, with a potential monetary policy shift expected in September. The focus is on August's non-farm payroll and inflation data, as well as adjustments to the annual non-farm benchmark [2] - In Europe, economic expectations are improving, and stable inflation allows the European Central Bank (ECB) to maintain current policy rates. ECB President Lagarde indicated that trade negotiations are not posing significant threats to monetary policy [2] Domestic Economy - Domestic economic growth slowed in July due to extreme weather and policy expectations, characterized by strong external demand and weak internal demand. Future external demand growth is expected to be supported by a weakening U.S. demand and a reshaped long-term trade landscape [3] - The domestic policy environment emphasizes stabilizing market expectations and strengthening the domestic circulation, with structural monetary policies focusing on inclusive finance and technological innovation [3][4] Fixed Income Research - In August, the central bank injected a net liquidity of 386.5 billion yuan, maintaining low funding prices. The issuance of interest rate bonds decreased to 3 trillion yuan, with net financing increasing to 1.7 trillion yuan [6][7] - The bond market is expected to face pressure from external demand uncertainties and "anti-involution" measures, with a focus on the stability of the funding environment in September [8] Industry Research - The medical insurance payment management method was introduced in August, and the 11th batch of centralized procurement is progressing. The medical care CPI in July was 100.5, with a year-on-year increase of 0.5% [9][10] - The pharmaceutical manufacturing industry reported a cumulative revenue of 1,401.07 billion yuan from January to July, a year-on-year decrease of 1.7%, while cumulative profits fell by 2.6% [10] - The upcoming World Lung Cancer Conference (WCLC) is expected to provide opportunities for innovation in the pharmaceutical and medical device sectors, with a focus on companies benefiting from optimized procurement rules and the recovery of domestic demand [10]

Industry Overview - The report highlights the upcoming World Lung Cancer Conference (WCLC) from September 6-9, 2025, in Barcelona, Spain, suggesting a focus on related corporate data updates and outcomes [11] - The report maintains a "positive" rating for the pharmaceutical and biotechnology industry, emphasizing opportunities in innovative drug and medical device sectors, particularly in light of expected interest rate cuts and optimized procurement rules [11][74] Industry News - In August, the National Medical Insurance Administration issued the "Interim Measures for Disease-Specific Payment Management," which clarifies policies related to disease-specific payments and aims to enhance transparency in budget management [18] - The report notes that 535 drug generic names passed the formal review for inclusion in the 2025 National Basic Medical Insurance and commercial health insurance innovative drug directories, indicating ongoing regulatory support for the industry [19] Industry Data - The Consumer Price Index (CPI) for healthcare in July was 100.5, reflecting a year-on-year increase of 0.5% and a month-on-month increase of 0.2% [20] - The Producer Price Index (PPI) for pharmaceutical manufacturing in July was 97.6, showing a year-on-year decrease of 2.4% and a month-on-month decrease of 0.5% [29] - Cumulative revenue for the pharmaceutical manufacturing industry from January to July was 1,401.07 billion, a year-on-year decrease of 1.7%, while cumulative profit totaled 194.82 billion, down 2.6% [31] Company Announcements - Heng Rui Medicine reported a 15.88% year-on-year increase in revenue for the first half of 2025, totaling approximately 15.76 billion, with a net profit of approximately 4.45 billion, reflecting a 29.67% increase [57] - The company received orphan drug designation from the FDA for its product, indicating strong potential for market support and development [58] Market Review - In August 2025, the Shanghai Composite Index rose by 7.97%, while the Shenzhen Component Index increased by 15.32%. The pharmaceutical and biotechnology sector saw a 2.61% increase, with most sub-sectors performing positively [59] - As of August 31, 2025, the price-to-earnings (P/E) ratio for the pharmaceutical and biotechnology industry was 31.18, with a valuation premium of 147% compared to the CSI 300 index [63]

Macro and Strategy Research - The liquidity environment is expected to improve, providing a mid-term layout window for the A-share market, with a focus on strengthening domestic circulation as a key policy direction [2][3] - The capital market is experiencing a liquidity-driven trend, with increased trading volume and a rise in margin financing balances, indicating a positive influx of funds into the market [3] Industry Research Metal Industry - The steel industry reported a revenue of CNY 945.23 billion in H1 2025, a year-on-year decrease of 9.16%, while net profit increased by 157.66% to CNY 13.14 billion, indicating significant improvement in overall performance [8] - The non-ferrous metal industry achieved a revenue of CNY 1,819.66 billion in H1 2025, a year-on-year growth of 6.49%, with net profit rising by 36.55% to CNY 95.36 billion, reflecting strong performance [10] Light Industry and Textile - The light industry manufacturing sector reported a revenue of CNY 297.01 billion in H1 2025, with a slight year-on-year increase of 0.01%, but net profit decreased by 23.14% to CNY 13.95 billion, indicating pressure on profitability [15] - The textile and apparel sector saw a revenue decline of 5.16% and a net profit decrease of 8.40% in H1 2025, highlighting challenges in the market [16] Pharmaceutical and Biotech - The pharmaceutical and biotech sector experienced a revenue decline in H1 2025, with innovative drugs and CXO segments showing strong performance, while medical devices faced pressure [18][19] - The chemical pharmaceutical segment reported a revenue of CNY 136.94 billion in Q2 2025, a year-on-year decrease of 1.4%, but net profit increased by 9.0%, indicating a recovery in profitability [19]

融资融券周报 主要指数多数上涨，两融余额继续上升 ――融资融券周报 | 分析师：王雪莹 | SAC NO：S1150525020001 2025 年 9 月 4 日 | | --- | --- | | 证券分析师 | 核心观点： | | 王[Table_IndInvest] 雪莹 | | |  022-23839121 | 市场概况 | | wangxy4430@bhzq.com  | 上周（8 月 27 日-9 月 2 日）A 股市场主要指数多数上涨，其中创业板 | | | 指涨幅最大，上涨了 4.74%；上证综跌幅最大，下跌了 0.26%。此外， | | | 深证成指上涨 0.65%，科创 50 上涨 4.52%，沪深 300 上涨 0.85%，上 | | | 证 上涨 0.78%，中证 下跌 0.03%。 50 500 | |  | 9 月 2 日，沪深两市两融余额为 22,811.21 亿元，较上周增加 808.89 亿 | | | 元。其中融资余额为 22,650.35 亿元，较上周增加 802.55 亿元；融券 | | | 余额为 160.85 亿元，较上周增加 6.34 亿元。每日平均参与 ...

Group 1: Metal Industry Insights - The steel industry is expected to see a rebound in demand in September, traditionally a peak consumption month, with potential price stability due to supply constraints from production limits and maintenance in regions like Tangshan [2][4] - Copper prices are supported by tight supply and potential demand recovery, with a focus on the upcoming Federal Reserve meeting which may influence price movements [2][5] - Aluminum prices are anticipated to remain stable, with demand expected to improve in the peak season, while supply is expected to hold steady [2][5] - Gold prices may see a moderate increase if inflation data meets expectations and employment data is weak, particularly ahead of the Federal Reserve's September meeting [3][7] - The rare earth market is experiencing increased overseas demand due to export controls, with potential price growth in September if overall demand remains strong [4][7] Group 2: Investment Strategies - For the steel sector, the "anti-involution" policy is expected to gradually improve the oversupply situation, with a focus on green and low-carbon transformation as a key driver for future growth [4][5] - In the copper sector, the tight supply situation is expected to support prices, and the "anti-involution" policy may improve the processing sector, making it a favorable investment area [5] - The aluminum sector is projected to benefit from new project capacities and supportive policies, with a recommendation to focus on companies with strong resource guarantees and environmental standards [5] - The rare earth sector is viewed positively due to regulatory changes and the strategic value of resources, with a recommendation to focus on companies involved in resource extraction and processing [7] Group 3: Machinery and Equipment Sector - The machinery and equipment sector has shown strong performance, with the industry index rising 12.67% from August 3 to September 2, outperforming the broader market [8] - The demand for construction machinery is expected to continue growing due to ongoing infrastructure projects and improved market conditions, particularly in the domestic market [8][9] - The humanoid robotics sector is gaining traction with advancements in computing platforms, indicating a critical phase for industry development and investment opportunities [9]

Group 1: A-Share Market Overview - In Q2 2025, the A-share market exhibited a "revenue growth without profit growth" characteristic, with a revenue growth rate of 0.5% and a net profit growth rate of 1.4% compared to Q1 2025, indicating a decline in profit margins [3][4] - The Sci-Tech Innovation Board showed relative strength, with improvements in both revenue and net profit growth rates, while large-cap stocks represented by the CSI 300 index demonstrated significant profit growth challenges [4][5] - The TMT sector maintained a relatively high level of net profit growth despite some marginal declines, reflecting the ongoing prosperity of the AI industry chain [4][5] Group 2: Liquidity and Policy Impact - The Politburo meeting emphasized enhancing the attractiveness and inclusiveness of the domestic capital market, indicating ongoing policy support for A-share liquidity [6][7] - The liquidity environment is characterized by a shift of household deposits towards the A-share market, which is expected to continue driving market performance [7][8] - Institutional investor participation has increased significantly, with insurance funds accelerating their investments in the stock market, contributing to the overall liquidity [7][8] Group 3: Fixed Income Market Insights - In August, the issuance rates for high-grade bonds increased while mid-to-low-grade bonds saw a decline, with overall changes ranging from -5 basis points to +3 basis points [9][11] - The credit bond market experienced a decrease in net financing, with various types of bonds showing mixed performance, but high-grade long-term bonds are highlighted for their investment value [9][11] - The real estate market is undergoing adjustments, with policies aimed at stabilizing the market expected to positively influence bond valuations [11][12] Group 4: Fund Market Dynamics - In August, the public fund market saw a significant increase in new fund issuance, with 80 new funds launched, raising a total of 454.70 billion yuan [13][15] - The performance of large-cap growth funds outperformed value funds, with the large-cap growth style rising by 15.45% [15] - The ETF market experienced substantial inflows, particularly in cross-border ETFs, indicating strong investor interest [19] Group 5: Traditional Chinese Medicine Industry - The Chinese traditional medicine market is projected to exceed 480 billion yuan in 2024, with a growth rate of 6%, supported by favorable policies and increasing international recognition [20][21] - Tianjin's traditional medicine industry has shown significant growth, with an industrial output value of 14.225 billion yuan in 2023, reflecting a 12.5% year-on-year increase [21][23] - Key companies in Tianjin's traditional medicine sector, such as Tianjin Tasly Pharmaceutical and others, are actively expanding their market presence and innovation capabilities [21][23] Group 6: Light Industry and Textile Sector - The implementation of new national standards for electric bicycles is expected to enhance the competitive advantage of leading companies in the sector [24][25] - The packaging paper prices are anticipated to continue rising, benefiting companies in the sector and improving their profitability [25][26] - The light industry and textile sectors have faced challenges, with performance lagging behind the broader market indices [24][25]

Group 1: Industry Overview - The new national standard for electric bicycles will be implemented on September 1, 2025, allowing old standard vehicles to be sold for an additional three months [10] - Leading paper companies have announced price increases, with paper prices expected to rise again in September [11] - From January to July, the retail sales of furniture increased by 22.60% year-on-year, while the revenue of the furniture manufacturing industry decreased by 5.40% [12][31] Group 2: Company Announcements - Oppein Home's net profit attributable to shareholders increased by 2.88% in the first half of 2025, with revenue of 8.241 billion yuan, a decrease of 3.98% year-on-year [46] - Aorijin's net profit attributable to shareholders increased by 64.66% in the first half of 2025, with revenue of approximately 1.173 billion yuan, a year-on-year increase of 62.74% [46] Group 3: Market Performance - From August 1 to August 31, the light industry manufacturing sector underperformed the CSI 300 index by 3.93 percentage points, with a return of 6.40% compared to the CSI 300's 10.33% [47] - The textile and apparel sector also underperformed the CSI 300 index by 7.62 percentage points, with a return of 2.71% [55] Group 4: Monthly Strategy - The implementation of the new national standard for electric bicycles is expected to enhance the competitive advantage of leading companies in the industry [57] - The price of corrugated paper has increased by 200 yuan/ton since August 1, and the price of boxboard has increased by 50 yuan/ton [59] - The domestic pet industry continues to develop steadily, with leading companies showing significant growth in their half-year reports [60]

晨会纪要（2025/09/02） 编辑人 022-28451618 SAC NO：S1150511010016 cuijian@bhzq.com 崔健 渤海证券研究所晨会纪要（2025.09.02） 宏观及策略研究 结构性因素拉动下，制造业景气边际改善——2025 年 8 月 PMI 数据点评 公司研究 业绩增速表现亮眼，聚焦机器人传感器领域——柯力传感（603662）2025 年 中报点评 主要产品量价齐升，增量项目持续推进——紫金矿业（601899）2025 年半年 报点评 晨 会 纪 要 请务必阅读正文之后的声明 渤海证券股份有限公司具备证券投资咨询业务资格 1 of 7 晨会纪要（2025/09/02） 宏观及策略研究 价格带动业绩增长，资源基础继续夯实——中金黄金（600489）2025 年半年 报点评 证 券 研 究 报 告 结构性因素拉动下，制造业景气边际改善——2025 年 8 月 PMI 数据点评 宋亦威（证券分析师，SAC NO：S1150514080001） 严佩佩（证券分析师，SAC NO：S1150520110001） 靳沛芃（研究助理，SAC NO：S1150124030005） ...

Macro and Strategy Research - The US durable goods orders showed a negative growth for the second consecutive month, while core capital goods orders turned positive, indicating stable investment demand from enterprises [2] - The European Central Bank (ECB) officials have differing views on inflation trends, suggesting a pause in rate cuts in September, with potential for easing later in the year due to economic uncertainties [3] - Domestic industrial enterprises' revenue growth continues to decline, but profit margins are improving, supported by previous "anti-involution" policies [3] Fixed Income Research - The bond market experienced a slight recovery before weakening again, with investor confidence remaining low [4] - The central bank's net injection of 167.6 billion yuan in the open market indicates a mixed performance in funding prices, with a divergence between cross-month and non-cross-month funding rates [5] - The supply pressure in the primary market for government bonds is expected to decrease in the remaining months of the year [6] Company Research: Haomai Technology (002595) - The company reported a revenue of 5.265 billion yuan for H1 2025, a year-on-year increase of 27.25%, and a net profit of 1.197 billion yuan, up 24.65% [8] - The company's core businesses are performing well, with significant growth in the CNC machine tool segment, which saw a revenue increase of 145.08% [9] - The new electric heating vulcanization machine has shown significant advantages and has received orders totaling 135 million yuan [10] Company Research: China Aluminum (601600) - The company achieved a revenue of 116.392 billion yuan in H1 2025, a 5.12% increase year-on-year, with a net profit of 7.071 billion yuan, up 0.81% [12] - Production of alumina and primary aluminum increased, with alumina production reaching 8.6 million tons, a 4.88% increase [14] - The company has improved its resource self-sufficiency rate and has accelerated the production of key projects [14]